Cvs Health CORP 8-K Filing
Ticker: CVS · Form: 8-K · Filed: Dec 9, 2025 · CIK: 64803
| Field | Detail |
|---|---|
| Company | Cvs Health CORP (CVS) |
| Form Type | 8-K |
| Filed Date | Dec 9, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Cvs Health CORP (ticker: CVS) to the SEC on Dec 9, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.01 (ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchange).
How long is this filing?
Cvs Health CORP's 8-K filing is 2 pages with approximately 576 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 576 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-12-09 06:33:11
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchange
Filing Documents
- cvs-20251209.htm (8-K) — 27KB
- cvs_ex99x1investorday2025.htm (EX-99.1) — 135KB
- a81cvs_healthxlogoxhxregxr.jpg (GRAPHIC) — 297KB
- cvs-20251209_g1.jpg (GRAPHIC) — 4KB
- 0000064803-25-000082.txt ( ) — 708KB
- cvs-20251209.xsd (EX-101.SCH) — 2KB
- cvs-20251209_lab.xml (EX-101.LAB) — 21KB
- cvs-20251209_pre.xml (EX-101.PRE) — 12KB
- cvs-20251209_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. In connection with its 2025 Investor Day, on December 9, 2025 , CVS Health Corporation issued a press release that, among other things, discussed its strategic priorities, updated its 2025 full-year financial guidance and provided its 2026 full-year financial guidance. A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 7.01 by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the "Exchange Act") or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing. Section 9 - Financial Statements and Exhibits
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . The exhibits to this Current Report on Form 8-K are as follows: INDEX TO EXHIBITS 99.1 Press Release of CVS Health Corporation dated December 9, 2025 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: December 9, 2025 By: /s/ Brian O. Newman Brian O. Newman Executive Vice President and Chief Financial Officer